Component
Rat regional extracellular serotonin
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
A modafinil dose ineffective alone augmented selected fluoxetine/imipramine serotonin responses, with dose/region-specific null combinations retained.
Experimental context and source evidence
- evidence_access
- Primary indexed abstract checked; full methods and figures not comprehensively reviewed.
- experimental_condition
- Antidepressant alone and low-dose modafinil alone low dose · Modafinil Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "Low-dose modafinil plus antidepressant", "comparator": "Antidepressant alone and low-dose modafinil alone", "endpoint": "A modafinil dose ineffective alone augmented selected fluoxetine/imipramine serotonin responses, with dose/region-specific null combinations retained.", "effect_direction": "mixed", "combination": "joint", "conditions": [{"entity_slug": "modafinil", "state": "low dose"}, {"entity_slug": null, "state": "fluoxetine or imipramine at tested dose"}]} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Rat drug-combination microdialysis; no demonstrated human clinical synergy or isolated hepatic mechanism.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
- plain_language
- A modafinil dose ineffective alone augmented selected fluoxetine/imipramine serotonin responses, with dose/region-specific null combinations retained.
- primary_references
- Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat. | 2005 | DOI 10.1002/syn.20111 | PMID 15668907 | https://pubmed.ncbi.nlm.nih.gov/15668907/
- source_locator
- Reviewed reference lines 97-97; exact primary location described in quoted passage where extracted.
Modafinil: detailed mechanisms of action (reviewed 3 October 2026) · lines 97–97
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Rat drug-combination microdialysis; no demonstrated human clinical synergy or isolated hepatic mechanism. · Recorded from source · Recorded from source
| Antidepressant coexposure | A low modafinil dose ineffective alone augmented particular fluoxetine/imipramine serotonin responses; effects depended on region and antidepressant dose, with null combinations retained. | A general prescription to combine drugs, a demonstrated human antidepressant synergy, or proof that the effect is solely a hepatic interaction. [2005 rat study](https://pubmed.ncbi.nlm.nih.gov/15668907/) |
Complete structured claim and evidenceModafinil increased extracellular serotonin in cortex, amygdala and dorsal raphe at lower doses than required in medial preoptic/posterior hypothalamic regions.
Experimental context and source evidence
- evidence_access
- Primary indexed abstract checked; full methods and figures not comprehensively reviewed.
- experimental_contrast
- {"intervention": "Modafinil", "comparator": "Matched regional baseline/control", "endpoint": "Modafinil increased extracellular serotonin in cortex, amygdala and dorsal raphe at lower doses than required in medial preoptic/posterior hypothalamic regions.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Awake-rat regional microdialysis; regional exposure-response differences.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
- plain_language
- Modafinil increased extracellular serotonin in cortex, amygdala and dorsal raphe at lower doses than required in medial preoptic/posterior hypothalamic regions.
- primary_references
- Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression. | 2002 | DOI 10.1002/jnr.10196 | PMID 11933055 | https://pubmed.ncbi.nlm.nih.gov/11933055/
- source_locator
- Reviewed reference lines 96-96; exact primary location described in quoted passage where extracted.
Modafinil: detailed mechanisms of action (reviewed 3 October 2026) · lines 96–96
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Awake-rat regional microdialysis; regional exposure-response differences. · Recorded from source · Recorded from source
| Serotonin | In awake rats, extracellular serotonin increased in cortex, amygdala and dorsal raphe at lower tested doses than those needed in medial preoptic/posterior hypothalamic regions. | Uniform serotonin elevation or identification of SERT as the principal clinical target. [2002 study](https://pubmed.ncbi.nlm.nih.gov/11933055/) |
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.